Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil plus triamcinolone versus triamcinolone for scar treatment
2014-003216-37Phase 2Active
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of verapamil and triamcinolone acetonide in Hypertrophic Scar (HS) and keloid (3 arms). Primary endpoint: Scar volume. Started Oct 2014; status: active.
02
Drugs
verapamiltriamcinolone acetonide
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on 2014-003216-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003216-37.